2017
DOI: 10.3892/ol.2017.7580
|View full text |Cite
|
Sign up to set email alerts
|

The expression and underlying angiogenesis effect of DPC4 and VEGF on the progression of cervical carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 32 publications
0
3
0
Order By: Relevance
“…When evaluating angiogenesis activity using antibodies to CD31, CD34, or CD105, correlations of MVD with cervical cancer prognosis were not revealed. In a study by Yani et al, the authors noted an increase in the level of VEGF and MVD in samples of squamous cell carcinoma compared with cervical inflammation and cervical intraepithelial neoplasia; however, there was no association of these markers with the stage of cervical cancer [ 56 ].…”
Section: Discussionmentioning
confidence: 99%
“…When evaluating angiogenesis activity using antibodies to CD31, CD34, or CD105, correlations of MVD with cervical cancer prognosis were not revealed. In a study by Yani et al, the authors noted an increase in the level of VEGF and MVD in samples of squamous cell carcinoma compared with cervical inflammation and cervical intraepithelial neoplasia; however, there was no association of these markers with the stage of cervical cancer [ 56 ].…”
Section: Discussionmentioning
confidence: 99%
“…The data obtained during a study of the role of the deletion at locus 4 of pancreatic carcinoma (DPC4) and vascular endothelial growth factor (VEGF) in the development of cervical cancer suggest that the loss of DPC4 and overexpression of VEGF may play an important role in the progression of cervical carcinoma. In cervical cancer, high levels of VEGF expression were found in cervical cancer [69]. VEGF plays an important role in tumor progression by inducing angiogenesis, while as a potent inhibitor of neovascularization, TSP-1 can inhibit angiogenesis in cervical carcinoma.…”
Section: Markers Of Angiogenesis In Cervical Carcinogenesismentioning
confidence: 99%
“…A possible mechanism for tumor progression is the loss of DPC4, which induces angiogenesis by increasing VEGF expression. Apparently, VEGF is a target gene regulated by DPC4, and negative expression of TSP 1 promotes angiogenesis; however, further studies are needed to assess the correlation between DPC4 and TSP 1 [69]. During examination of 44 women with advanced cervical carcinoma, before the beginning of therapy a biopsy and a blood sample were taken from each patient, the density of micro vascularization was assessed in the biopsy material using antibodies to CD34, and the expression of angiogenic factors VEGFR, EGFR, and COX-2 was determined.…”
Section: Markers Of Angiogenesis In Cervical Carcinogenesismentioning
confidence: 99%